BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Topics
»
Disease categories and therapies
» Hematologic
Hematologic
RSS
Pharmacokinetics and safety of lotrafiban assessed in phase II trial
March 26, 1999
Nonbenzamidine factor Xa inhibitors in the pipeline at Rhone-Poulenc Rorer
March 25, 1999
Suntory presents SUN-C5174, a 5-HT2 antagonist with potent antiplatelet activity
March 25, 1999
Novel thrombin inhibitor series from 3-D discussed at ACS meeting
March 25, 1999
Bristol-Myers Squibb announces Spanish launch of antiplatelet drug
March 25, 1999
ACS highlights: 3-D progresses in development of new class of thrombin inhibitors
March 24, 1999
Texas Biotechnology resubmits Novastan NDA
March 24, 1999
Another anticoagulant series presented by DuPont at the ACS meeting
March 23, 1999
ACS highlights: new noncovalent thrombin inhibitors described by Merck & Co.
March 23, 1999
DuPont presents potent and selective factor Xa inhibitors
March 23, 1999
Previous
1
2
…
404
405
406
407
408
409
410
411
412
…
480
481
Next
RSS